Published in Biotech Business Week, April 9th, 2007
Fourth Quarter and Year 2006 Financial Results
Revenue for the fourth quarter of 2006 was $6.4 million compared to $222,000 for the fourth quarter of 2005. Revenue for the year-ended December 31, 2006 was $36.5 million compared to $349,000 for the year-ended December 31, 2005. Revenue in 2006 was earned through the company's strategic collaboration with Wyeth and consisted of collaborative research...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.